Oct 06, 2017 10:30 am UTC| Business
HOUSTON, Oct. 06, 2017 -- Buckeye Partners, L.P. (“Buckeye”) (NYSE:BPL) is scheduled to release its 2017 third quarter earnings on November 3, 2017. Interested parties are invited to listen to the conference call on...
Havertys Reports Sales for Third Quarter
Oct 06, 2017 10:25 am UTC| Business
ATLANTA, Oct. 06, 2017 -- HAVERTYS (NYSE:HVT) (NYSE:HVT.A) today reported sales for the quarter ended September 30, 2017. Havertys sales for the third quarter 2017 decreased 1.9% to $207.6 million, compared with...
Consumers with Pet Allergy Have a New Option for Dander Control
Oct 06, 2017 10:20 am UTC| Business
LANDOVER, Md., Oct. 06, 2017 -- The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) have announced that three Kenmore vacuums made by Cleva North America have earned asthma allergy...
Kalnin Ventures Announces Fifth Marcellus Asset Acquisition
Oct 06, 2017 10:00 am UTC| Business
DENVER, Oct. 06, 2017 -- Kalnin Ventures LLC (“Kalnin”) today announced that an affiliate of its BKV Oil and Gas Capital Partners, LP fund (the “Fund”), has entered into Purchase and Sale Agreements with respect to the...
Visit Inspirata at CAP, ‘The Pathologists’ Meeting,’ Next Week
Oct 06, 2017 10:00 am UTC| Business
Tampa, FL, Oct. 06, 2017 -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that it will be exhibiting in Booth #802 at the College of American Pathologists (CAP)...
Metso appoints three Business Area heads and Executive Team members
Oct 06, 2017 07:03 am UTC| Business
Metso appoints three Business Area heads and Executive Team members Metso Corporation, stock exchange release, October 6, 2017 at 10:00 EEST Relating to the changes in Metso's operating model and organization...
Motif Bio Presents New Pre-Clinical Data for Iclaprim at IDWeek 2017™
Oct 06, 2017 06:00 am UTC| Business
1. Pre-Clinical Data Support the Potential Use of Iclaprim in the Treatment of Staphylococcus aureus Pneumonia in Cystic Fibrosis Patients 2. Iclaprim Demonstrates Potent In Vitro Suppression of Exotoxins in MRSA...